Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of $121.22 million. The enterprise value is $33.45 million.
| Market Cap | 121.22M |
| Enterprise Value | 33.45M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.59% |
| Owned by Institutions (%) | 8.89% |
| Float | 963.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.81 |
| Forward PS | 3.52 |
| PB Ratio | 0.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.06, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.06 |
| Quick Ratio | 10.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -198.82 |
Financial Efficiency
Return on equity (ROE) is -13.10% and return on invested capital (ROIC) is -17.82%.
| Return on Equity (ROE) | -13.10% |
| Return on Assets (ROA) | -12.40% |
| Return on Capital (ROIC) | -17.82% |
| Revenue Per Employee | $174,903 |
| Profits Per Employee | -$233,597 |
| Employee Count | 144 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 2.00 |
Taxes
| Income Tax | -1.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.47% in the last 52 weeks. The beta is 0.98, so Zomedica's price volatility has been similar to the market average.
| Beta (1Y) | 0.98 |
| 52-Week Price Change | -42.47% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 36.94 |
| Average Volume (30 Days) | 4,781,383 |
Short Selling Information
The latest short interest is 63.99 million, so 6.53% of the outstanding shares have been sold short.
| Short Interest | 63.99M |
| Short Previous Month | 64.63M |
| Short % of Shares Out | 6.53% |
| Short % of Float | 6.64% |
| Short Ratio (days to cover) | 11.47 |
Income Statement
In the last 12 months, Zomedica had revenue of $25.19 million and -$33.64 million in losses. Loss per share was -$0.04.
| Revenue | 25.19M |
| Gross Profit | 17.32M |
| Operating Income | -43.25M |
| Pretax Income | -34.97M |
| Net Income | -33.64M |
| EBITDA | -33.96M |
| EBIT | -34.79M |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $90.50 million in cash and $2.73 million in debt, giving a net cash position of $87.77 million or $0.09 per share.
| Cash & Cash Equivalents | 90.50M |
| Total Debt | 2.73M |
| Net Cash | 87.77M |
| Net Cash Per Share | $0.09 |
| Equity / Book Value | 240.02M |
| Book Value Per Share | 0.24 |
| Working Capital | 90.85M |
Cash Flow
In the last 12 months, operating cash flow was -$15.98 million and capital expenditures -$11.34 million, giving a free cash flow of -$27.31 million.
| Operating Cash Flow | -15.98M |
| Capital Expenditures | -11.34M |
| Free Cash Flow | -27.31M |
| FCF Per Share | -$0.03 |
Margins
Gross margin is 68.76%, with operating and profit margins of -171.73% and -133.56%.
| Gross Margin | 68.76% |
| Operating Margin | -171.73% |
| Pretax Margin | -138.84% |
| Profit Margin | -133.56% |
| EBITDA Margin | -134.85% |
| EBIT Margin | -138.15% |
| FCF Margin | -108.45% |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -27.75% |
| FCF Yield | -22.53% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zomedica has an Altman Z-Score of 4.65 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.65 |
| Piotroski F-Score | 2 |